Jay R. Luly

2012

In 2012, Jay R. Luly earned a total compensation of $771.6K as President and Chief Executive Officer at Enanta Pharmaceuticals, a 26% increase compared to previous year.

Compensation breakdown

Bonus$213,914
Option Awards$145,736
Salary$407,482
Other$4,439
Total$771,571

Luly received $407.5K in salary, accounting for 53% of the total pay in 2012.

Luly also received $213.9K in bonus, $145.7K in option awards and $4.4K in other compensation.

Rankings

In 2012, Jay R. Luly's compensation ranked 7,189th out of 11,487 executives tracked by ExecPay. In other words, Luly earned more than 37.4% of executives.

ClassificationRankingPercentile
All
7,189
out of 11,487
37th
Division
Manufacturing
2,571
out of 4,252
40th
Major group
Chemicals And Allied Products
658
out of 1,200
45th
Industry group
Drugs
455
out of 922
51st
Industry
Pharmaceutical Preparations
357
out of 697
49th
Source: SEC filing on January 15, 2015.

Luly's colleagues

We found two more compensation records of executives who worked with Jay R. Luly at Enanta Pharmaceuticals in 2012.

2012

Yat Or

Enanta Pharmaceuticals

Chief Scientific Officer

2012

Paul Mellett

Enanta Pharmaceuticals

Chief Financial Officer

News

You may also like